Maxygen's board approves $10M boost to repurchase plan
This article was originally published in Scrip
Executive Summary
Maxygen has said that its board of directors has approved an increase to the company's current stock repurchase programme from $10 million to $20 million. Maxygen joins many others this year in repurchasing stock, aiming to boost investors' confidence. The programme is to expire 31 December.